Feasibility of CD3/CD19 depletion of a bone marrow graft

Halvard Bonig1, Ingo Müller2

  • 1Institute for Transfusion Medicine and Immunohematology, Division of Translational Cell Therapy, Goethe University, Frankfurt and German Red Cross Blood Service Baden-Württemberg-Hesse, Frankfurt, Germany; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, United States.

Cytotherapy
|August 14, 2016
PubMed
Abstract

No abstract available in PubMed .